Literature DB >> 21886735

A case of psoriasis worsened by atorvastatin.

Emanuele Cozzani1, Manuela Scaparro, Aurora Parodi.   

Abstract

Statins are known to have a number of cutaneous adverse effects including the induction of autoimmune diseases like systemic and subacute lupus erythematosus, dermatomyositis, polymyositis, lichen planus pemphigoides and the drug reaction with eosinophilia and systemic symptoms (DRESS). Statins have been also reported as a triggering factor of psoriasis. We report a case of psoriasis vulgaris that worsened three months after atorvastatin was introduced and improved after its discontinuance.

Entities:  

Keywords:  adverse events; atorvastatin; drug eruptions; psoriasis; statins

Year:  2009        PMID: 21886735      PMCID: PMC3163346          DOI: 10.3315/jdcr.2009.1037

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  6 in total

Review 1.  Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review.

Authors:  B Noël
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-01       Impact factor: 6.166

2.  [Cutaneous adverse effects of statins].

Authors:  J-L Schmutz; A Barbaud; P Tréchot
Journal:  Ann Dermatol Venereol       Date:  2008-03-04       Impact factor: 0.777

3.  [Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)].

Authors:  L Gressier; C Pruvost-Balland; L Dubertret; M Viguier
Journal:  Ann Dermatol Venereol       Date:  2008-11-28       Impact factor: 0.777

4.  A mechanistic study on the phototoxicity of atorvastatin: singlet oxygen generation by a phenanthrene-like photoproduct.

Authors:  Sara Montanaro; Virginie Lhiaubet-Vallet; MariaRosaria Iesce Iesce; Lucio Previtera; Miguel Angel Miranda
Journal:  Chem Res Toxicol       Date:  2009-01       Impact factor: 3.739

5.  Transition of psoriasiform drug eruption to psoriasis de novo evidenced by histopathology.

Authors:  Mayuko Yamamoto; Mitsunori Ikeda; Hajime Kodama; Shigetoshi Sano
Journal:  J Dermatol       Date:  2008-11       Impact factor: 4.005

Review 6.  Drugs in exacerbation of psoriasis.

Authors:  E A Abel; L M DiCicco; E K Orenberg; J E Fraki; E M Farber
Journal:  J Am Acad Dermatol       Date:  1986-11       Impact factor: 11.527

  6 in total
  4 in total

1.  Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis.

Authors:  William C Ports; Rana Fayyad; David A DeMicco; Rachel Laskey; Robert Wolk
Journal:  Clin Drug Investig       Date:  2017-08       Impact factor: 2.859

2.  The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials.

Authors:  Mateusz Socha; Aldona Pietrzak; Ewelina Grywalska; Daniel Pietrzak; Dariusz Matosiuk; Paweł Kiciński; Jacek Rolinski
Journal:  Arch Med Sci       Date:  2019-12-06       Impact factor: 3.318

3.  A Case of Psoriasis Vulgaris Aggravated with Atorvastatin, Aided by Concomitant Cyclosporine.

Authors:  Kenit P Ardeshna; Shylaja Someshwar; Shaurya Rohatgi; Hemangi R Jerajani
Journal:  Indian J Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.494

4.  Antipsychotic-associated psoriatic rash - a case report.

Authors:  Camelia-Eugenia Bujor; Torkel Vang; Jimmi Nielsen; Ole Schjerning
Journal:  BMC Psychiatry       Date:  2017-07-04       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.